Q&A

  • Questions for David Mandell: Curbing autism's costs
    20 January 2015
    Comments ( 4 )

    Existing autism therapies do little to lower the lifetime costs of having the disorder, so clinicians should consider more efficient and inexpensive alternatives, says David Mandell.

  • Questions for Eric London: Alternative diagnoses for autism
    2 January 2015
    Comments ( 7 )

    Names such as autism, schizophrenia and intellectual disability are ‘umbrella’ terms that muddy the search for the true cause of an individual’s symptoms, says Eric London. He plans to come up with an alternative diagnostic scheme for developmental disabilities over the next two years.

  • Questions for Thomas Insel: Paths to treatments for autism
    24 November 2014
    Comments ( 0 )

    Finding people who have an autism-linked mutation but no apparent symptoms may be the key to identifying drug targets for the disorder, says Thomas Insel, director of the National Institute of Mental Health.

  • Questions for Karen Parker: Probing monkey social behavior
    4 November 2014
    Comments ( 0 )

    Like people, monkeys vary widely in their social abilities. Behavioral neuroscientist Karen Parker explains how studying social behavior in monkeys can advance how we understand and treat autism.

  • Questions for Joseph Cubells: Folic acid's impact on autism
    7 October 2014
    Comments ( 4 )

    It’s been 15 years since researchers published an epidemiological study with results so striking they sparked worldwide changes in food fortification. Geneticist Joseph Cubells is revisiting the results to determine whether folate decreases autism risk.